Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 14 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 2 completed trials have results

Key Signals

3 recruiting

Enrollment Performance

Analytics

N/A
1(100.0%)
1Total
N/A(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (14)

Showing 14 of 14 trials
NCT07116096Not ApplicableRecruiting

Effect of Handgrip Strength on Portal Vein Hemodynamics in Patients With Liver Cirrhosis

Role: collaborator

NCT04896255Recruiting

Long-term Outcomes of Anti-viral Therapies in Patients With Chronic Viral Hepatitis B

Role: collaborator

NCT06392503Recruiting

Noninvasive Diagnosis Model for High-risk Varices in Cirrhosis

Role: collaborator

NCT05965388Not Yet Recruiting

Predictive Value of HBV pgRNA on Long-term Outcomes in Hepatitis B Patients Treated With Antiviral Therapy

Role: collaborator

NCT05551884Unknown

Non-invasive Diagnosis of Portal Hypertension in Cirrhosis Based on Metabolomics Technology

Role: collaborator

NCT05052892Unknown

A Novel Spleen-dedicated Stiffness Measured by FibroScan to Evaluate Cirrhotic Portal Hypertension (CHESS2105)

Role: collaborator

NCT05100485Completed

Algorithm to Stratify Clinical Decompensation Risk in Patients With Compensated Advanced Chronic Liver Disease (CHESS2108)

Role: collaborator

NCT04883177Completed

Effectiveness and Safety of the COVID-19 Vaccination for Patients With Liver Disease (CHESS2101)

Role: collaborator

NCT05251272Unknown

A Combined Model Based on Spleen Stiffness, Liver Stiffness and Platelets for Assessing Portal Hypertension in Compensated Cirrhosis (CHESS2202)

Role: collaborator

NCT05140837Unknown

Early Diagnosis and Timely Treatment of Cirrhotic Patients With Minimal Hepatic Encephalopathy (CHESS-NCRCID 2106)

Role: collaborator

NCT05538546Unknown

Baveno VI Criteria in Dynamic Monitoring of High-risk Varices in Compensated Cirrhotic Patients

Role: collaborator

NCT05402410Unknown

An AI Model Based on Smartphone-derived Multimodality Images to Evaluate Portal Hypertension in Patients With Cirrhosis (CHESS2203)

Role: collaborator

NCT05204602Unknown

Safety and Immunogenicity of COVID-19 Vaccine Booster in Patients With Liver Diseases

Role: collaborator

NCT03108794Unknown

A Nation-wide Hospital-based Hepatitis B Registry:China Registry of Hepatitis B

Role: collaborator

All 14 trials loaded